HighVista Strategies »

Viatris shares owned by HighVista Strategies

Quarter-by-quarter ownership of Viatris (VTRS) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Viatris

Tip: Access up to 7 years of quarterly data

All positions including Viatris held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viatris by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 103k 11.94

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Merus N V (MRUS)
Microsoft Corporation (MSFT)
Arcellx Common Stock (ACLX)
Xpo Logistics Inc equity (XPO)
Nuvalent Inc-a (NUVL)
Ansys (ANSS)
Hess (HES)
Ideaya Biosciences (IDYA)
Juniper Networks (JNPR)
Sp Plus (SP)
Cerevel Therapeutics Hldng I (CERE)
Albertsons Cos Common Stock (ACI)

View all positions for HighVista Strategies

Top funds holding Viatris

Vanguard Group
BlackRock
T. Rowe Price Associates
Davis Selected Advisers
Geode Capital Management
Pacer Advisors
Deerfield Management Company
Ameriprise Financial
Rubric Capital Management
Morgan Stanley
Dimensional Fund Advisors
Bank of New York Mellon
Charles Schwab Investment Management
Northern Trust
AustralianSuper Pty

View all funds holding Viatris